IBIS Therapeutics enters into a strategic collaboration agreement with Mayo Clinic
The collaboration is described as supporting the discovery of novel and repurposed drug candidates suitable for clinical development.
Updates from IBIS Therapeutics.
Selected news items currently featured on the live IBIS Therapeutics website.
IBIS Therapeutics: AI-driven approaches to therapeutic efficacy
The live site highlights an AI engine capable of predicting absorption, distribution, metabolism, excretion and toxicity to help identify promising candidates.
XLerateHealth selects seven healthcare startups for its 2020 accelerator cohort
This historical item remains part of the public news archive.